Literature DB >> 3053763

Immunoblot analysis of serologic response to outer membrane proteins of Escherichia coli in elderly individuals with urinary tract infections.

L E Nicolle1, E Ujack, J Brunka, L E Bryan.   

Abstract

We used immunoblotting to examine the serologic antibody responses to outer membrane proteins (OMP) of Escherichia coli in both symptomatic and asymptomatic elderly subjects with urinary tract infections. Controls with no present or past urinary tract infections showed variable weak immunoglobulin G (IgG) antibodies to OMP of infecting strains. Elderly individuals with asymptomatic infections demonstrated antibody to both lipopolysaccharide (LPS) and OMP of their infecting strain, with consistent cross-reactivity to OMP of other infecting strains. Young females with acute pyelonephritis showed an IgG response to LPS and OMP with cross-reactivity to OMP of other strains. Elderly individuals with symptomatic invasive infections had strong reactions to both LPS and OMP in specimens collected during the acute phase, generally with an increase in intensity in specimens from convalescent patients. They also demonstrated extensive cross-reactivity to LPS and OMP from all other infecting strains. IgM antibody was not observed in any patients. These data confirm other reports of low levels of antibodies to OMP of E. coli in normal populations. Asymptomatic bacteriuria in this population is associated with antibody responses to the LPS and OMP of the infecting strain. Elderly individuals with invasive infections had initial reactions to the infecting strain with an apparent increase in intensity during convalescence. Antibodies to the major OMP appear to be broadly cross-reactive.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053763      PMCID: PMC266821          DOI: 10.1128/jcm.26.10.2087-2091.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier.

Authors:  R E Hancock; H Nikaido
Journal:  J Bacteriol       Date:  1978-10       Impact factor: 3.490

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The senescence of the immune system.

Authors:  M E Weksler
Journal:  Hosp Pract (Off Ed)       Date:  1981-10

6.  Urinary tract infections in the elderly.

Authors:  D Kaye
Journal:  Bull N Y Acad Med       Date:  1980-03

7.  Major outer membrane proteins of Escherichia coli strains of human origin.

Authors:  N Overbeeke; B Lugtenberg
Journal:  J Gen Microbiol       Date:  1980-12

8.  Bacteriuria in elderly institutionalized men.

Authors:  L E Nicolle; J Bjornson; G K Harding; J A MacDonell
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

9.  Major outer membrane proteins: common antigens in enterobacteriaceae species.

Authors:  H Hofstra; J Dankert
Journal:  J Gen Microbiol       Date:  1980-07

10.  Community-acquired bacteremia in the elderly: analysis of one hundred consecutive episodes.

Authors:  A L Esposito; R A Gleckman; S Cram; M Crowley; F McCabe; M S Drapkin
Journal:  J Am Geriatr Soc       Date:  1980-07       Impact factor: 5.562

View more
  4 in total

1.  A strong antibody response to the periplasmic C-terminal domain of the OmpA protein of Escherichia coli is produced by immunization with purified OmpA or with whole E. coli or Salmonella typhimurium bacteria.

Authors:  R Puohiniemi; M Karvonen; J Vuopio-Varkila; A Muotiala; I M Helander; M Sarvas
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine.

Authors:  Ho Young Kang; Jay Srinivasan; Roy Curtiss
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.

Authors:  N Moayeri; C M Collins; P O'Hanley
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

4.  Optimizing antibiotics in residents of nursing homes: protocol of a randomized trial.

Authors:  Mark Loeb; Kevin Brazil; Lynne Lohfeld; Allison McGeer; Andrew Simor; Kurt Stevenson; Stephen Walter; Dick Zoutman
Journal:  BMC Health Serv Res       Date:  2002-09-03       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.